< Return to previous page

Deborah Kilpatrick

Evidation Health
CEO

Deborah Kilpatrick, PhD is the CEO of digital health company Evidation Health in CA. Evidation is a new kind of health and measurement company that provides the world’s most innovative healthcare companies technology and expertise to understand how everyday behavior and health interact. Previously, Deborah was the Chief Commercial Officer of genomic diagnostics company CardioDx, whose Corus CAD product was named in the Wall Street Journal Technology Innovation Awards and TIME Magazine’s Top 10 Medical Breakthroughs. Earlier in her career, she held multiple leadership roles in R&D and New Ventures at Guidant Corporation prior to its acquisition by Boston Scientific (NYSE: BSX). She currently sits on the Georgia Tech College of Engineering Advisory Board, is a Director for Sleep Number (NASDAQ: SNBR) and is a Fellow of the American Institute of Medical and Biological Engineering. A co-founder of the MedtechVision Conference now held annually in Silicon Valley, Deborah has also has been named to FierceBiotech’s Top Women in Biotech and FierceMedicalDevice’s Top Women in Medtech. She holds B.S., M.S. and Ph.D. degrees in engineering from Georgia Tech.

Read Full Bio

Deborah Kilpatrick

Evidation Health
CEO